6533b880fe1ef96bd12d6a60
RESEARCH PRODUCT
Additional file 2 of Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey
Laura D’erasmoAntonio GalloAngelo Baldassare CefalùAlessia Di CostanzoSamir SahebAntonina GiammancoMaurizio AvernaAlessio BuonaiutoGabriella IannuzzoGiuliana FortunatoArturo PujaTiziana MontalciniChiara PavanelloLaura CalabresiGiovanni Battista VignaMarco BucciKatia BonomoFabio NotaTiziana SampietroFrancesco SbranaPatrizia SuppressaCarlo SabbàFabio FimianiArturo CesaroPaolo CalabròSilvia PalmisanoSergio D’addatoLivia PisciottaStefano BertoliniRanda BittarOlga KalmykovaSophie BéliardAlain CarriéMarcello ArcaEric Bruckertsubject
lipids (amino acids peptides and proteins)description
Additional file 2: Figure 1. LDL-C burden according to lomitapide or LA treatment. A Box plot graphs represent the median values of cumulative LDL-C burden in the Lomitapide cohort (dark grey) and in the LA cohort (light grey). For the total LDL-C burden calculation see Methods. P values are adjusted for age at follow-up, untreated LDL-C values and gender. B, C Box plot graphs represent the median values of TC and LDL-C burden at baseline and on-treatment. For baseline and on-treatment TC or LDL-C burden calculation see Methods. Δ% represents TC and LDL-c percent reduction from baseline and is reported with the respective statistical significance. B shows data form Lomitapide cohort whereas C those from LA cohort.LDL-C, low density lipoprotein cholesterol, LA, Lipoprotein apheresis.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2021-01-01 |